ASX - By Stock
|
ADX |
Re:
Ann: Anshof-3 Production Recommences
|
|
Teddyward
|
21 |
8.5K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
21
|
8.5K
|
4
|
|
ASX - By Stock
|
STO |
Re:
STO Well positioned
|
|
Teddyward
|
541 |
244K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
541
|
244K
|
2
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Teddyward
|
1.1K |
447K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.1K
|
447K
|
3
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Anshof-3 Production Recommences
|
|
Teddyward
|
21 |
8.5K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
21
|
8.5K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: March 2024 Quarterly Activity Report & Appendix 4C
|
|
Teddyward
|
12 |
2.3K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
12
|
2.3K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: March 2024 Quarterly Activity Report & Appendix 4C
|
|
Teddyward
|
12 |
2.3K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
12
|
2.3K
|
2
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Awarded second US DoD contract
|
|
Teddyward
|
30 |
7.5K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
30
|
7.5K
|
0
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Awarded second US DoD contract
|
|
Teddyward
|
30 |
7.5K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
30
|
7.5K
|
0
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Teddyward
|
1.1K |
447K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.1K
|
447K
|
1
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Redflow Strategy Update
|
|
Teddyward
|
9 |
2.0K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
9
|
2.0K
|
3
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Redflow Strategy Update
|
|
Teddyward
|
9 |
2.0K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
9
|
2.0K
|
7
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Teddyward
|
1.1K |
447K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.1K
|
447K
|
1
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Teddyward
|
1.1K |
447K |
6 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.1K
|
447K
|
6
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Investor Presentation - with Welchau-1 Data Review
|
|
Teddyward
|
24 |
9.7K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
24
|
9.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
Teddyward
|
451 |
139K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
451
|
139K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Teddyward
|
29 |
5.3K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Teddyward
|
29 |
5.3K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Teddyward
|
29 |
5.3K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Teddyward
|
29 |
5.3K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Teddyward
|
53 |
12K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Change in substantial holding
|
|
Teddyward
|
100 |
19K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
100
|
19K
|
7
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Teddyward
|
53 |
12K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Teddyward
|
53 |
12K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
YOW |
Re:
Ann: Resignation of Executive Chairman
|
|
Teddyward
|
1 |
546 |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1
|
546
|
0
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Change in substantial holding
|
|
Teddyward
|
100 |
19K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
19K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Teddyward
|
29 |
5.3K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Teddyward
|
53 |
12K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
53
|
12K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Teddyward
|
53 |
12K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
Teddyward
|
13 |
2.2K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.2K
|
0
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Redflow undertakes capital raising
|
|
Teddyward
|
61 |
19K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
61
|
19K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Application for quotation of securities - NUH
|
|
Teddyward
|
40 |
9.2K |
4 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
40
|
9.2K
|
4
|
|
ASX - By Stock
|
RFX |
Re:
Redflow NEWS & EVENTS
|
|
Teddyward
|
1.6K |
493K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.6K
|
493K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
28K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
28K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
Teddyward
|
19 |
2.6K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
19
|
2.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
28K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
Teddyward
|
19 |
2.6K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
19
|
2.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Confirmation Bias
|
|
Teddyward
|
3 |
530 |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
3
|
530
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
Teddyward
|
19 |
2.6K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
19
|
2.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
Teddyward
|
19 |
2.6K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
19
|
2.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Vulture Capitalists
|
|
Teddyward
|
11 |
2.2K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
11
|
2.2K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Initiates Strategic Review Supported by $1.85M Cap Raise
|
|
Teddyward
|
145 |
29K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
145
|
29K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
New xxsbiz interview on Starpharma/Medicxi $38 million deal
|
|
Teddyward
|
13 |
2.0K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
13
|
2.0K
|
2
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Initiates Strategic Review Supported by $1.85M Cap Raise
|
|
Teddyward
|
145 |
29K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
145
|
29K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
148
|
28K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
148
|
28K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Teddyward
|
32 |
6.2K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Teddyward
|
32 |
6.2K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Teddyward
|
32 |
6.2K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Teddyward
|
148 |
28K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
148
|
28K
|
4
|
|